Citius Pharmaceuticals Inc (CTXR)

NASDAQ
1.210
-0.050(-3.97%)
After Hours
1.240
+0.030(+2.479%)
- Real-time Data
  • Volume:
    637,570
  • Day's Range:
    1.210 - 1.270
  • 52 wk Range:
    0.831 - 2.250

CTXR Overview

Prev. Close
1.26
Day's Range
1.21-1.27
Revenue
-
Open
1.24
52 wk Range
0.831-2.25
EPS
-0.209
Volume
637,570
Market Cap
176.82M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
631,072
P/E Ratio
-5.64
Beta
1.48
1-Year Change
-40.39%
Shares Outstanding
146,129,630
Next Earnings Date
Dec 14, 2022
What is your sentiment on Citius Pharma?
or
Market is currently closed. Voting is open during market hours.

Citius Pharmaceuticals Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Citius Pharmaceuticals Inc Analysis

Citius Pharmaceuticals Inc Company Profile

Citius Pharmaceuticals Inc Company Profile

Employees
10

Citius Pharmaceuticals Inc. specialty pharmaceutical company. The Company develops and commercializes critical care products with a focus on anti-infective products in adjunct cancer care, prescription products and mesenchymal stem cell therapy. It has five products: Mino-Lok, Mino-Wrap, Halo-Lido, NoveCite and I/ONTAK. Mino-Lok is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections by salvaging the infected catheter. Mino-Wrap is a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries. Halo-Lido is a corticosteroid-lidocaine topical formulation, which is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids. NoveCite is a mesenchymal stem cell therapy for the treatment of ARDS. I/ONTAK is an engineered IL-2 diphtheria toxin fusion protein, for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma.

Read More

Analyst Price Target

Average4.400 (+263.64% Upside)
High6
Low3.2
Price1.21
No. of Analysts3
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellNeutralSell
Technical IndicatorsStrong SellStrong SellStrong SellSellStrong Sell
SummaryStrong SellStrong SellStrong SellNeutralStrong Sell
  • I’m in too, its undervalue
    0
    • I just jumped in today !
      1
      • long term lotto ffhl
        1
        • russel 2000 and phase 3 results next week, even if we see a correction today i'm not slightly worried. long on citius, i've done some deep DD and i am leaving my money in there for a good year at the very least
          2
          • I need more time for my transanction then buy more stuff. Long term is incredible due to great stock.
            0
        • Nice bounce back, hopefully no one sold the dip in panic
          0
          • Just regular correction for long day bullish stock, I guess it gonna back on track for sure.
            0
            • To quote a value investing mastermind, I like the stock
              0
              • sorry guys. just bought in. that's why it sunk on you. my bad.
                0
                • a part, the message with "to the Moon", someone want to start a discussion about some estimate about the next value of CTXR, with concrete informations?
                  0
                  • to mars🚀
                    0
                  • Some of you guys are funny. You demand trustworthy DD for free from user of free stocks platform…
                    1
                • Coming soon, I am sure this stock will go to the moon.
                  0